Symbol
YMAB
Investment type
Equity / Common stock, par value $0.0001 per share
Latest Disclosed Ownership
2.65M shares
Security Ownership
5.84%

Glazer Capital, LLC ownership in Y-mAbs Therapeutics, Inc. Common stock, par value $0.0001 per share (YMAB)

2025-08-15 - Glazer Capital, LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.65M shares of Y-mAbs Therapeutics, Inc. Common stock, par value $0.0001 per share (YMAB). This represents 5.84% percent ownership of the company.